These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34359096)
1. Clinical performance of a commercially available thymidine kinase 1 assay for diagnosis of lymphoma in 42 hospitalized horses (2017-2020). Moore C; Stefanovski D; Luethy D J Vet Intern Med; 2021 Sep; 35(5):2495-2499. PubMed ID: 34359096 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma. Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077 [TBL] [Abstract][Full Text] [Related]
3. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma. Larsdotter S; Nostell K; von Euler H Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802 [TBL] [Abstract][Full Text] [Related]
4. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma. Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918 [TBL] [Abstract][Full Text] [Related]
5. Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer. Selting KA; Ringold R; Husbands B; Pithua PO J Vet Intern Med; 2016 Jul; 30(4):1159-66. PubMed ID: 27214230 [TBL] [Abstract][Full Text] [Related]
6. Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions. Perkins GA; Nydam DV; Flaminio MJ; Ainsworth DM J Vet Intern Med; 2003; 17(3):337-42. PubMed ID: 12774976 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma. Mattsson Ulfstedt J; Venge P; Holmgren S; Enblad G; Eriksson S; Molin D Ups J Med Sci; 2021; 126():. PubMed ID: 34471484 [TBL] [Abstract][Full Text] [Related]
8. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management. Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881 [TBL] [Abstract][Full Text] [Related]
9. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker. Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716 [TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation. Gatt ME; Goldschmidt N; Kalichman I; Friedman M; Arronson AC; Barak V Anticancer Res; 2015 May; 35(5):3019-26. PubMed ID: 25964590 [TBL] [Abstract][Full Text] [Related]
11. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker. Jagarlamudi KK; Shaw M Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979 [TBL] [Abstract][Full Text] [Related]
12. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206 [TBL] [Abstract][Full Text] [Related]
13. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma. Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596 [TBL] [Abstract][Full Text] [Related]
14. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib. Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma. Sharif H; Saellström S; Kolli B; Jagarlamudi KK; Wang L; Rönnberg H; Eriksson S Front Vet Sci; 2023; 10():1243853. PubMed ID: 37808109 [TBL] [Abstract][Full Text] [Related]
16. Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses. Borges AS; Divers TJ; Stokol T; Mohammed OH J Vet Intern Med; 2007; 21(3):489-94. PubMed ID: 17552456 [TBL] [Abstract][Full Text] [Related]
18. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity. He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366 [TBL] [Abstract][Full Text] [Related]
19. Markers for internal neoplasia in the horse. Drozdzewska K; Gehlen H Vet Med Sci; 2023 Jan; 9(1):132-143. PubMed ID: 36495211 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic assessment of peritoneal fluid cytology in horses with abdominal neoplasia]. Recknagel S; Nicke M; Schusser GF Tierarztl Prax Ausg G Grosstiere Nutztiere; 2012 Apr; 40(2):85-93. PubMed ID: 22526721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]